AtriCure, Inc. (A5I)
FSX
41.80
+0.40 (+0.97%)
Closed
Aug 25, 2026
Day's Range
41.8041.80
52 wk Range
21.8041.80
Financial Statements - A5I - AtriCure, Inc.
Revenue
534.52M▲ 35.7%
Net Income
-11.44M▲ 69.7%Net Margin -2.1%
EBITDA
16.24M▲ 211.7%
Free Cash Flow
42.28M▲ 543.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 534.52M | 393.92M | 399.24M | 330.37M | 274.32M | 206.53M |
| Cost of Goods | 133.74M | 99.71M | 98.87M | 84.43M | 68.46M | 57.22M |
| Gross Profit | 400.77M | 294.21M | 300.37M | 245.94M | 205.86M | 149.30M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -9.44M | -33.87M | -26.68M | -42.66M | -47.29M | -44.59M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 683K | -1.42M | -31K | -537K | 102.13M | 333K |
| Pre Tax Income | -10.16M | -36.97M | -29.84M | -46.19M | 50.38M | -48.04M |
| Income Tax | 1.28M | 866.91K | 591K | 268K | 188K | 114K |
| Net Income | -11.44M | -37.84M | -30.43M | -46.46M | 50.19M | -48.15M |
| EPS Basic | -0.24 | -0.95 | - | - | - | -1.14 |
| EPS Diluted | -0.24 | -0.95 | - | - | - | -1.14 |
| Basic Shares Outstanding | 47.75M | 39.76M | - | - | - | 42.12M |
| Diluted Shares Outstanding | 47.75M | 39.76M | - | - | - | 42.12M |
| Ebit | -4.28M | -31.55M | -22.92M | -41.21M | 55.30M | -43.15M |
| Ebitda | 16.24M | -14.53M | -8.10M | -29.50M | -36.75M | -33.96M |
| Net Income Continuous Operations | -11.44M | -37.84M | -30.43M | -46.46M | 50.19M | -48.15M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
